OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

2025-03-31-accounts

University Hospitals Bristol & Weston Charity

Working name: Bristol & Weston Hospitals Charity

Report and Accounts for the Year Ended 31[st] March 2025

University Hospitals Bristol & Weston Charity Company Number: 10394287 Registered Charity Number: 1170973 Registered Office: 6[th ] Floor, Whitefriars, Lewins Mead, Bristol BS1 2NT

1

Contents:

Contents:
Report and Accounts for the Year Page
Annual Report:
1
Chair and CEO introduction
3
2
Trustees’ report:
5
i
Whywe exist
5
ii
Grants and impact
6
iii
Fundraisingand engagement
10
iv
Financial review
12
v
Investmentpolicy
13
vi
Reservespolicy
15
vii
Principal risks and uncertainties
17
viii Lookingforward 18
3
Governance and leadership
19
i
Charityinformation
19
ii
Trustees and the leadershipteam
20
iii
Staff and Remuneration
23
iv
Grant makingand fund structure
23
v
Fundraising policy
24
vi
Equity, Equality, Diversity& Inclusion
26
vii
Other administrative information
28
4
Statement of Trustees’ responsibilities
29
Audit report for theyear ended 31/03/2025 31
Balance sheet as at 31/03/2025 36
Statement of Financial Activity (SOFA)as at 31/03/2025 37
Statement of cash flows as at 31/03/2025 38
Notes to the financial statements 40

2

1. Chair and CEO introduction

This year has been a special one for Bristol & Weston Hospitals Charity. With thanks to our generous supporters, not only have we have raised £2.4m and invested £1.6m into our hospitals, we have also celebrated a special milestone: our 50[th] anniversary.

For half a century, our charity has stood alongside patients, families and the staff who care for them, going above and beyond what the NHS alone can provide. Since our founding in 1974, generations of supporters have funded groundbreaking equipment, created healing environments and backed pioneering research, always with one shared goal: to make our hospitals the very best they can be.

This year that spirit has shone brighter than ever. From abseilers, skydivers and runners to impactful partnerships with local businesses and volunteers who give hours of their time each week to support our patients. We are so grateful for the full-hearted community of special people who make a real difference at our hospitals.

These efforts helped us award £1.6m in new grants this year, from sensory bags to psychological support for cardiac patients and families of cancer patients, and from period poverty support packs to the creation of dementia-friendly wards.

It has also been particularly humbling to witness the outpouring of support during Baby Loss Awareness Week for our award-winning Snowdrop Appeal, which raised funds to refurbish eight bereavement spaces across St Michael’s and Weston General Hospitals for families who experience the devastation of pregnancy and baby loss while in hospital.

This year has also been a period of change and transition in preparation for delivering a new five-year strategy and leadership change. After eight impactful years as CEO, Paul Kearney stepped down shortly after the yearend. Since joining in 2017, Paul played a pivotal role in growing our income, strengthening our partnership with University Hospitals Bristol and Weston

3

NHS Foundation Trust (UHBW), and positioning the charity as a key NHS partner. We are deeply grateful for his outstanding contribution.

Following an external recruitment process, we were pleased to appoint an internal candidate, Katie Walker, as our new Chief Executive, bringing both continuity and fresh momentum as we step into this next chapter and begin delivering our ambitious new strategy. Katie was also joined by Jennifer Davies as Director of Finance and Operations and Sarah Pryer as Director of Fundraising and Marketing, who both took up post shortly after year-end, bringing renewed energy as we look ahead.

To every donor, fundraiser, volunteer, NHS colleague and Trustee: thank you. Your support has continued to make a huge difference. With your help, we’re carrying forward our proud 50-year legacy with a renewed determination to keep transforming the hospital experience, with the dignity, compassion and hope that every patient deserves.

The last 50 years have been remarkable – and with your continued support, the next 50 will be even more extraordinary.

David Wynick Chair

Katie Walker

Chief Executive

4

2. Trustees’ report

i. Why we exist

charity partner to UHBW, which includes:

Other community services through:

Our vision: To improve the health and happiness of every patient cared for by our hospitals.

Working in partnership with UHBW, every patient cared for by our hospitals has access to outstanding treatment in hospital environments which match the first-class care they receive from NHS staff.

Our purpose: We’re here to bring moments of joy, comfort and hope to those who need it most.

We help our hospitals and their staff to do even more to treat and care for patients. We push the limits of what is possible where the NHS is unable to, going above and beyond to transform the experience patients receive at our hospitals, wherever the need is greatest.

5

We do this by: Partnering with our wonderful Bristol and Weston communities to fundraise and raise as much as we can together; whether that’s patients, local businesses or trusts and foundations. Working with our partner NHS Trust, UHBW, to fund the things which matter most to patients and staff.

of the Charities Act 2011 to have due regard to the Charity Commission’s guidance on public benefit.

Bristol & Weston Hospitals Charity exists to improve the health and wellbeing of patients, families and NHS staff at UHBW and within the wider community. Through charitable donations and partnerships, the charity funds projects that enhance patient experience, improve hospital environments, support NHS staff wellbeing, and enable access to innovative treatments and technologies.

All activities undertaken during the year were in furtherance of these charitable purposes and were for the benefit of the public, in accordance with the charity’s governing documents and the Charity Commission’s public benefit requirements.

ii. Grants and impact

Thanks to the generosity of our supporters, we awarded £1.6m in grants in 2024–25, funding 299 projects across UHBW, 88% of the total amount awarded directly benefited patients and the remaining 12% helped to support NHS staff wellbeing.

funding priorities.

6

Our grants broken down by funding priority for 2024-2025:

Little things that make a big difference

Dementia ward improvements

Thanks to your generous support, we've been able to make improvements to Wards A524 and A522 - elderly care wards at the Bristol Royal Infirmary.

The improvements have included:

Thanks to these changes, falls have decreased by 39% and incidents of violence and aggression have decreased by 45% .

7

It has also improved morale among staff. Comments have included...

Healing environments

Last year, we asked the people of Bristol and Weston to help us raise money for our Snowdrop Appeal, an appeal to transform eight hospital spaces in St Michael’s Hospital and Weston General Hospital for families experiencing devastating pregnancy and baby loss. These spaces were gloomy, clinical and outdated and in dire need of love to help bring families comfort when they need it most.

The time bereaved families have together is traumatically short. Working alongside the Snowdrop Team, Elle, Maddie and Laura, we wanted to do everything we could so that if the worst happens, families are surrounded by the gentlest and most carefully considered environments.

The improvements to the spaces have been shortlisted in the 2025 Patient Experience Awards.

Thanks to all our kind donors for supporting this full-hearted project and our snowdrop families. You shared the love and helped us raise over £45.3k to make this project a reality.

8

Many patients on Wards A602 and A604 at the Bristol Royal Infirmary are elderly or nearing the end of their life and many can’t get outside during their hospital stay. New murals help to brighten up the space for patients and help it to feel less claustrophobic during a long stay.

In total, approximately 200 patients, 120 staff and 100 hospital visitors have benefited from the new artwork.

Staff also said it made the ward environment more welcoming and friendly, as well as lifting the mood.

Equitable access for all

Thanks to our amazing supporters, we have been able to continue funding the hospital shuttle buses for another year, ensuring they remain free of charge for all patients, staff and visitors.

The buses travel around Bristol city centre and Weston-superMare, ensuring our hospitals are easily accessible to all.

In total, around 6,000 patients, staff and visitors use the bus service every month.

World-class technology, treatments, knowledge and research

The ultimate aim of the research is a rapid, reliable and low-cost prostate cancer test that would result in reduced waiting lists. The patients would have an enhanced experience - they would not need to attend clinic and give a blood sample, which is needed by the current NHS PSA test. The current PSA test for prostate cancer can have raised values without prostate cancer and these false positive results can cause unnecessary patient anguish and investigations, which then has a secondary knock-on effect on NHS waiting times and cost budgets, including MRI scans and biopsy tests.

9

In terms of health economics, if the new test is proved to be more accurate than the PSA, it could be used to reduce the number of patients who then proceed to MRI and biopsy (which are uncomfortable and not without risk for patients) with a significant cost saving.

It could also spawn more research projects related to prostate cancer detection.

iii. Fundraising and engagement

In 2024–25, the charity raised £2.4m through fundraising, thanks to the commitment of our incredible community of donors, fundraisers, and partners.

Lottery

Our weekly lottery remains a vital source of unrestricted income. Continued strategic investment during the year laid the foundation for future growth and income stability. By the end of the financial year, just over 19,000 tickets were in play from over 14,500 players, and the lottery raised £843k. This is supplemented by the quarterly superdraw product.

Community and events

Highlights included:

10

Legacy and in-memory giving

Legacy income exceeded expectations, with many individuals choosing to leave a lasting gift. In-memory fundraising continued to be a powerful expression of gratitude and connection and saw a wide range of activity and giving to celebrate loved ones. These gifts totalled £920k. We also we have revitalised our legacy marketing programme to secure this important stream for the future.

Individual supporters

Much of our support comes from individual people in our community, often saying thank you for the care they or a loved one has had in hospital. Together, these supporters raised over £180k. Our Snowdrop Appeal was a big part of this, reaching a wide community of existing and new supporters.

Partnerships

We worked with a wide range of businesses and charitable trusts to fund projects, raise awareness, and extend our reach.

We are particularly proud of the three-year partnership we have had with Deloitte, who donated £128k via fundraising, payroll giving and corporate match funding. This support has enabled us to deliver a holistic learning programme in Bristol Children’s Hospital, which helps narrow the significant opportunity gap for young people in hospital. We’ve funded specialist teachers to deliver STEM sessions building digital expertise, cooking classes building valuable life skills, and drama, singing and music to improve confidence and creativity. The programme supported over 1,000 children in the first three years and has now been renewed for a further three years. In addition to the money raised, the partnership has delivered significant non-financial benefits, including weekly Deloitte volunteering supporting the school team, laptops for our staff, training and development opportunities, and a Pilotlight Hackathon Day attended by senior Deloitte staff, which directly contributed ideas and content to our new five-year strategy.

Our partnership with Glastonbury Festivals has also been a highlight, with over £100k donated in the last two years, supporting multiple

11

projects across our hospitals. 2024 also saw our most successful corporate Christmas appeal yet, with over £11k raised.

Volunteers

Our committed volunteers contributed 1,815 hours of their time across events, shops, hospital and office roles. We are incredibly grateful for our 62 volunteers and 35 crafters for their amazing support.

iv. Financial review

In 2024–25, we raised £2.4m of income from donations, legacies and trading activities, with a further £1.3m from investments and other income sources, bringing total income to £3.7m. Income this year also includes £185k of back rent following a rent review on some of our investment properties.

We awarded £1.6m in grants across 299 projects, helping to transform care, improve environments, and support staff wellbeing.

While investment markets experienced volatility late in the year, leading to an unrealised loss of £305k, the position has since recovered post year-end. Trustees remain confident in the long-term investment strategy, with funds managed by Cazenove in a specialist sustainable multi-asset charity fund. The charity also undertook a valuation exercise on its investment properties, resulting in a gain of £780k.

We continued to invest in the growth of our weekly lottery, which is expected to provide a more stable source of unrestricted income in future years. In its early years, the lottery requires significant outlay on player acquisition and prize costs, but as participant numbers build towards a steady base it is expected to deliver a sustainable return. Trustees view this as a strategic investment to diversify income and strengthen long-term financial resilience.

At year-end, total funds stood at £18.4m, of which £18.3m was unrestricted. Free reserves - the portion of unrestricted funds not

12

upfront investment in the lottery programme. Trustees continue to monitor reserves carefully to balance long-term financial sustainability with maximising charitable impact.

v. Investment policy

acceptable level of risk by prudently investing in property, quoted securities, and cash deposits. Investment decisions consider available dividend and rental yields, as well as the potential for long-term capital growth.

Investments are made with guidance from the charity’s specialist property and investment advisors. The portfolio is managed by Cazenove through a dedicated Charity Sustainable Multi-Asset Fund. This fund is designed specifically for the charity sector and offers the following features:

13

The fund’s investment approach:

The fund also engages actively with companies and fund managers to influence progress towards the UN Sustainable Development Goals and collaborates with others in the sector to drive wider industry change.

Investments are screened to exclude fossil fuels, alcohol, pornography, armaments, tobacco, gambling and high-interest lending.

Investment income for the period amounted to £1.1m, of which £563k came from property, £477k from dividends and £12k from interest. The total portfolio was valued at £17.3m, of which property was £7.1m and investments held with Cazenove in a Multi-Asset Fund was £10.2m. In addition, there was cash held at the bank and on deposit of £916k.

valuation in accordance with the RICS Valuation – Global Standards 2025 and the UK National Supplement effective from 1[st] May 2024 and reissued in January 2025 (Red Book), FRS102 and the SORP for Charities, by a third party, Alder King, in September 2025. The Trustees are satisfied that the valuations remain appropriate and represent the best estimate of fair value as of 31[st] March 2025.

14

vi. Reserves policy

The charity holds reserves to ensure it can meet its ongoing commitments and respond flexibly to the evolving needs of patients across UHBW and its associated community services. Grants are awarded in line with our four funding priorities (from the 1[st] of April 2025):

Purpose of reserves

Reserves are maintained to:

Reserve requirement

Trustees aim to hold free reserves equivalent to:

15

Reserve target calculation Year
to 31/03/25
£000’s
Year
Year
to 31/03/24
£000’s
Support costs 810 810
792
Governance related costs 128 128
150
Cost of fundraising: staff and office costs 1,612 612
1,390
Adjustment to normalise lotterycosts (153)
Total costs for theperiod 2,397 397
2,333
Six-month reserve required 1,199 1,199
1,166
Other costs
Redundancyestimate 101 101
84
Grant making 100
Non-cancellable operating leases – 12
months
92 92
99
Estimated administration costs to close 50 50
50
Total other costs 243 243
333
Total reserve required 1,442 1,442
1,499

As of 31[st] March 2025, the charity held free reserves of £1.4m, £60k below the target level. A further £1k was held within the charity’s subsidiary company. The small shortfall reflects continued strategic investment in long-term income growth, particularly the development of the regular giving lottery programme. Trustees are confident this is a temporary position and that income from these initiatives is expected to grow steadily over the coming years.

Designated and restricted funds

The charity holds a number of designated funds where donations have been earmarked by the trustees to reflect the stated preferences of donors (for example, to benefit a particular hospital within the Trust or clinical area). Although these funds are not legally restricted and can be reallocated by the trustees, if necessary, the charity seeks to honour the donors’ wishes wherever possible.

At year end there were 233 designated funds totalling £16.9m. Grant commitments (amounts approved but not yet spent) were £1.7m.

16

Summary of group reserves (as of 31[st] March 2025) Fund type £’000 Restricted funds 90 Designated funds 16,923 Unrestricted – free reserves 1,382 Subsidiary company reserves 1 Total 18,396

The reserves policy is reviewed annually by the Audit Committee and was most recently approved by the Board of Trustees on the 28[th] of November 2025.

vii. Principal risks and uncertainties

The Trustees maintain a comprehensive risk register which is reviewed regularly by the Senior Management Team and Board.

The highest rated risks in the 2024-25 were:

17

viii. Looking forward

and ambitious plan built around two goals that aim to improve the health and happiness of every patient cared for in our hospitals.

Our strategic goals:

1. Increase our charitable impact

We will fund more projects that improve outcomes, reduce health inequalities, and enhance patient and staff experience. Shifting our priority areas of impact to:

18

2. Grow and diversify our income

We will build a more sustainable income base through prioritising those most likely to give through focused audience strategies and building impact-led strategic partnerships.

To do this we will:

3. Governance and leadership

i. Charity information

The charity is a charitable company limited by guarantee, registered in England and Wales (Company No. 10394287, Charity No. 1170973), and regulated by the Charity Commission and Companies House. The charity holds a Gambling Commission licence for the operation of its weekly lottery.

Originally incorporated on 1[st] October 2018, the charity received the assets and undertakings of The Charitable Trusts for University Hospitals Bristol. On 1[st] October 2021, the funds of Weston Health General Charitable Fund were transferred into the charity, and the charity changed its name from Above & Beyond to Bristol & Weston Hospitals Charity.

The Charity has one 100% subsidiary, Education Centre Management Limited (company number 04026846), whose principal activity is the

19

management of the Education Centre, a facility for the provision of medical training in Bristol.

ii. Trustees and the leadership team

Trustees

The charity is governed by a Board of Trustees who are responsible for setting strategic direction, overseeing the use of charitable funds, and ensuring compliance, risk management, and delivery of public benefit. Trustees also serve as company directors.

The Board meets quarterly and delegates certain responsibilities to two sub-committees: Finance & Grants and Audit. Each committee operates under agreed terms of reference and reports to the full Board.

As of 31[st] March 2025, there were 13 Trustees. Trustees are typically appointed for a four-year term and may serve a maximum of eight years (two terms), unless extended by a two-thirds majority vote of the Board. In some cases, terms have been extended to support continuity and governance needs – for example, two Trustee’s terms were reset when the charity became an independent entity. Trustees may be appointed by Ordinary Resolution or by a simple majority vote of eligible Trustees at a Board meeting, provided the individual meets legal eligibility criteria.

In May 2024, the Board agreed to increase the maximum number of Trustees beyond 12 to support succession planning and broaden the skills and experience on the Board.

As part of our close working relationship with UHBW, one of our Trustee positions is typically held by a UHBW employee nominated by the Trust. During the year this role was held by Chief Nurse Deirdre Fowler, who stepped down shortly after the year end.

New Trustees are recruited through open advertisement and receive a full induction and access to ongoing training.

20

The Trustees who served during the year and up to the date of the approval of the Financial Statements were:

Name Period of appointment
David Wynick (Chair) Appointed 22ndMay 2024
Lee Aston Chair of Audit Committee
Appointed 1stApril 2017
Steven Bluff Appointed 1stApril 2017
Resigned 24thJuly2024
Benjamin Breeze Appointed 22ndMay 2024
Stephen Campling Chair of Finance & Grants Committee until
12thSeptember 2024
Appointed 23rdMay2019
Deirdre Fowler (NHS Trust nominee) Appointed 28thJuly 2021
Resigned 9thJune 2025
James Fox (Vice Chair) Vice Chair of Trustees, Chair of Finance &
Grants Committee from 12thSeptember 2024
Appointed 1stApril 2017
Carlos Leira Appointed 25thMay 2022
Bishrut Mukherjee Appointed 22ndMay 2024
Jane Oakland Appointed 22ndMay 2024
Jane Palmer Appointed 23rdMay 2019
Rajnish Razdan Appointed 22ndMay 2024
Terence Rice Appointed 25thMay 2022
Clare Titley Appointed 25thMay 2022
Victoria FitzGerald Appointed 25thSeptember 2025
Sarah Dodds Appointed 25thSeptember 2025

Audit Committee

Audit Committee
Name Period of appointment
Lee Aston Appointed 22ndSeptember 2017
Chair of Audit Committee -
Appointed 10thFebruary2022
Steven Bluff Appointed 17thNovember 2022
Resigned 24thJuly2024
Terence Rice Appointed 17thNovember 2022
Jane Oakland Appointed 1stMarch 2025

21

Finance & Grants Committee

Finance & Grants Committee
Name Period of appointment
James Fox (Vice Chair) Appointed 11thMay 2022
Vice Chair of Trustees, Chair of Finance &
Grants Committee from 12thSeptember 2024
Jane Palmer Appointed 22ndMay2022
Ben Breeze Appointed 12thSeptember 2024
Bishrut Mukerjee Appointed 13thFebruary 2025
Carlos Leira Appointed 13thFebruary 2025

The Trustees maintain a formal register of interests, and Trustees are asked to declare any potential conflicts at the start of every meeting. New Trustees receive an induction, and all Trustees are offered training and development opportunities throughout their term.

The Trustees undertake periodic reviews of governance, composition and ways of working, and continue to monitor these on an ongoing basis to ensure they remain effective and aligned with best practice

The Trustees oversee charitable funds that support enhancements across UHBW hospitals and associated community services, as well as the wider NHS where appropriate. In doing so, they maintain a policy of only funding activity that falls outside of core NHS responsibilities.

Senior Management Team

The Board delegates day-to-day operations to the Senior Management Team (SMT), who oversee the charity’s strategic delivery, performance, and risk management.

In April 2025, Chief Executive Paul Kearney stepped down after almost eight years, and Director of Finance & Operations Sue Perrott also left the charity. Following an external recruitment process, internal candidate Katie Walker was appointed as Chief Executive, and was joined by Sarah Pryer (internal candidate) and Jennifer Davies (external candidate) to form the new SMT.

22

Chief Executive Paul Kearney (until 11[th] April 2025) Katie Walker (from 1[st] April 2025) Director of Finance & Sue Perrott (until 25[th] April 2025) Operations Jennifer Davies (from 28[th] April 2025) Director of Fundraising Katie Walker (until 1[st] April 2025) & Marketing Sarah Pryer (from 1[st] April 2025)

The Trustees review a scheme of delegation annually and retain ultimate responsibility for strategic decisions, grant-making over £50k and oversight of risk and investment.

iii. Staff and remuneration

At 31[st] March 2025, the charity employed 30 staff. Employees who joined pre-October 2018 are members of the NHS pension scheme; those who joined since are enrolled in a defined contribution scheme.

The Trustees consider all staff remuneration in the same way on an annual basis. Their pay policy allows for an annual cost of living increase, which is benchmarked against the voluntary sector. In addition, they review and benchmark all roles either when it needs to be recruited or as required. This is done in conjunction with an independent external HR adviser.

All Trustees give their time freely and no Trustee remuneration was paid in the year. Details of Trustee expenses are disclosed in note nine to the Accounts.

iv. Grant making and fund structure

Grant approvals are managed in line with a scheme of delegation approved by Trustees, with appropriate oversight from the Finance & Grants Committee and the Board.

23

Funds are categorised as follows:

v. Fundraising policy

The charity is reliant on the kindness and generosity of supporters to help improve the lives of patients in our hospitals.

Our approach

We promote the charity locally and partner with individuals, community organisations, companies and charitable trusts and foundations to maximise the difference we can make for our hospitals.

We are committed to fundraising in an honest and respectful way and our fundraising approach reflects our charity values. Campaigns, appeals and activities are planned, delivered and reviewed regularly to ensure they further the charity’s purpose whilst ensuring resources are used efficiently and ethically to achieve sustainable income growth.

Regulation

We are registered with the Fundraising Regulator and comply with the Code of Fundraising Practice and the regulator’s Fundraising Promise. In line with growth of our charity lottery, we hold a large society licence with the Gambling Commission and comply with the Licencing Conditions and Code of Practice to prevent crime, ensure fairness and transparency and to safeguard vulnerable people. Our partner external

24

lottery provider also holds their own operating licence with the Gambling Commission.

How we monitor fundraisers

Our charity fundraising and marketing team cultivate, develop and maintain relationships with supporters in line with our Supporter Charter and Fundraising Promise published on our website.

The charity is a member of NHS Charities Together. As a member charity we have the opportunity to benchmark our fundraising activity with our peers, discuss matters of common concern, exchange information and participate in conferences and seminars which offer support and education for our staff and trustees.

We work with a professional fundraising agency to promote our charity lottery within a number of hospital locations. The agency was selected following a rigorous tender process and in recognition of their approach to fundraising within sensitive hospital environments. Fundraisers undertake comprehensive training and their performance is continually monitored and reviewed in accordance with our lottery policies and procedures.

Complaints

Our relationship with our supporters is very important to us and we monitor feedback and take complaints seriously.

When we receive a complaint, we endeavour to resolve it quickly, fairly and effectively. We recognise we can continue to improve the charity’s effectiveness, by listening and responding to the views of our supporters, partners and stakeholders and by responding positively to complaints.

We aim to ensure that:

25

During the year the charity received 13 formal complaints all of which were recorded, resolved and acted on (where appropriate). 12 of these were regarding having fundraisers on site to promote the charity lottery.

Protecting vulnerable supporters

We take our responsibilities to protect vulnerable people seriously and follow the guidance on treating donors fairly and make sure all our agency partners are fully aware of our policies.

We have a Vulnerable Person’s Policy and specify minimum and maximum age ranges to our agency partners, so that we never recruit new donors who are too young, too vulnerable or too elderly to consent.

We are always sensitive to signs that may indicate that any individual is in vulnerable circumstances and needs support to make an informed decision. If we reasonably believe the individual lacks capacity to make a decision, then a donation will not be accepted or will be returned if already made.

vi. Equity, Equality, Diversity & Inclusion (EEDI)

A fairer future for all

We believe in a fairer future for all, and we know that by working together we can achieve, much more. We believe that everyone has the right to live without fear or prejudice regardless of sex, marital or civil partnership status, pregnancy or maternity, sexual orientation, religion or belief, gender re-assignment (whether proposed, ongoing, or completed), race (including colour, nationality, ethnic or national origin), age, or disability.

26

Everyone should be able to contribute fully to society in their own unique way and live in a world which demonstrates respect and values diversity.

Our responsibility

Bristol & Weston Hospitals Charity (“BWHC”) complies with the Equality Act 2010 (the “Act”) and understands our duties under it. As an organisation we would treat any reports of discrimination seriously. Should such a report arise, BWHC will ensure it is investigated and appropriate action taken in line with our internal policies and procedures.

Our principles

BWHC is committed, though, to do more than just adhere to the Act. We strive to create an inclusive workplace and, in addition to a programme of Equity, Equality, Diversity and Inclusion training for our staff and Trustees, have launched an EEDI action plan, setting out key activities for all BWHC charity staff and Trustees to work towards:

Our vision

Our aim is to achieve a more equitable, diverse, and inclusive workforce by ensuring EEDI is reflected in our values and embedded in our practises and individual behaviours.

We expect all our third-party suppliers and partners to commit to treating their workforce with dignity and respect, in addition to complying with the Act.

27

Equal opportunity

We are committed to the provision of equal opportunities and the charity’s policy is to treat all applicants, candidates, third parties and employees in the same way, regardless of sex, marital or civil partnership status, pregnancy or maternity, sexual orientation, religion or belief, gender re-assignment (whether proposed, ongoing, or completed), race (including colour, nationality, ethnic or national origin), age, or disability. The equal opportunities policy always applies and should influence the way in which individuals treat their colleagues, clients, candidates, visitors, third parties and contacts.

vii. Other administrative information

Legal advisors Lyons Davidson, Bristol
Withers LLP,London
Auditors Moore Kingston Smith LLP,London
Investment managers Cazenove Capital,London
Land/Propertyagents Alder King,Bristol

The charity also holds a number of memberships:

• Fundraising Regulator

The charity is a member of the Fundraising Regulator which was created in June 2016, replacing the Fundraising Standards Board (FRSB). The FR holds the code of fundraising practice for the

28

www.fundraisingregulator.org.uk

Since introducing a new charity lottery requiring a licence with the Gambling Commission, the charity is a member of the Lotteries Council, which acts on behalf of all Society Lottery promoters and works closely with the Gambling Commission. Members are regulated by a Code of Practice and are thus regarded as being responsible lottery operators by the public, legal authorities and potential contributors.

from sharing best practice, advice and shared experience of sector challenges.

4. Statement of Trustees’ responsibilities

The Trustees are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

each financial period that give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing those financial statements, the Trustees are required to:

29

The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charitable company and to enable them to ensure that the financial statements comply with the Companies Act 2006.

They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the Trustees are aware:

The Trustees’ Annual Report is approved by the Trustees of the charity.

Signed on behalf of the Trustees on 28[th] November 2025.

David Wynick Chair of Trustees

30

INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS AND TRUSTEES OF UNIVERSITY HOSPITALS BRISTOL & WESTON CHARITY

Opinion

We have audited the financial statements of University Hospitals Bristol & Weston Charity (the ’company’) for the year ended 31 March 2025 which comprise the Group Statement of Financial Activities, the Group and Parent Charitable Company Balance Sheets, the Group Cash Flow Statement and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs(UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

31

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and parent charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the trustees’ annual report.

We have nothing to report in respect of the following matters where the Companies Act 2006 and the Charities Act 2011 require us to report to you if, in our opinion:

32

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement set out on page 29, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the group and parent charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the group or parent charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed as auditor under the Companies Act 2006 and section 151 of the Charities Act 2011 and report in accordance with those Acts.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

33

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the charitable company.

Our approach was as follows:

34

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions reflected in the financial statements. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

Use of our report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and, in respect of the consolidated financial statements, to the charity’s trustees, as a body, in accordance with Chapter 3 of Part 8 of the Charities Act 2011. Our audit work has been undertaken so that we might state to the charitable company’s members and trustees those matters which we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to any party other than the charitable company, the charitable company’s members, as a body, and the charity’s trustees, as a body, for our audit work, for this report, or for the opinion we have formed.

Adam Fullerton (Senior Statutory Auditor) for and on behalf of Moore Kingston Smith LLP, Statutory Auditor

9 Appold Street London EC2A 2AP

Date: 05/12/2025

Moore Kingston Smith LLP is eligible to act as auditor in terms of Section 1212 of the Companies Act 2006.

35

University Hospitals Bristol & Weston Charity

Consolidated and Charity Balance Sheets

For the Year Ended 31 March 2025

Note
Fixed assets
Tangible fixed assets
10
Intangible fixed assets
11
Investments
12
Heritage assets
13
Group
Group
Charity
Charity
31.03.2025
31.03.2024
31.03.2025
31.03.2024
£ '000's
£ '000's
£ '000's
£ '000's
70
97
70
97
-
1
-
1
17,341
17,281
17,341
17,281
38
92
38
92
Total fixed assets 17,449
17,471
17,449
17,471
Long term debtors
Debtors
14
1,222
1,727
1,222
1,727
Current assets
Debtors
14
Cash at bank and in hand
1,743
1,102
1,756
1,115
952
2,287
916
2,252
Total current assets
Creditors: amounts due within one year
15
2,695
3,389
2,671
3,367
(2,841)
(3,275)
(2,818)
(3,254)
Net current assets (146)
114
(147)
113
Total assets less current liabilities 18,526
19,312
18,525
19,311
16
Creditors: amounts falling due after more than one
year
(130)
(634)
(130)
(634)
Net assets 18,396
18,678
18,395
18,677
Funds
Income funds
Restricted
21
Unrestricted funds:
Designated funds
21
General funds
21
90
160
90
160
16,923
17,224
16,923
17,224
1,383
1,294
1,382
1,293
Total funds 18,396
18,678
18,395
18,677

A separate Statement of Financial Activities is not presented for the Charity itself, as the Charity has taken advantage of the exemptions afforded by Section 408 of the Companies Act 2006. The net expenditure of the Charity for the period was £282k (2024: net income £124k).

Approved by the Trustees on 28 November 2025 and signed on their behalf by

David Wynick (Chair)

Lee Aston (Trustee)

Company number: 10394287

36

University Hospitals Bristol & Weston Charity

Consolidated Statement of Financial Activities

For the Year Ended 31 March 2025

==> picture [448 x 428] intentionally omitted <==

----- Start of picture text -----
Year to Year to Year to Year to Year to Year to
31.03.2025 31.03.2025 31.03.2025 31.03.2024 31.03.2024 31.03.2024
Unrestricted Restricted Total Unrestricted Restricted Total
Note £ '000's £ '000's £ '000's £ '000's £ '000's £ '000's
Income and endowments from:
Donations 443 106 548 397 368 765
Legacies 894 - 894 732 - 732
Charitable activities 226 - 226 206 - 206
Other trading activities 2 930 - 930 613 - 613
Investments 3 1,052 - 1,052 950 - 950
Other income 12 - 12 1 - 1
Total income and endowments 3,557 106 3,662 2,899 368 3,267
Expenditure:
Raising funds:
Fundraising costs 4 1,612 - 1,612 1,391 - 1,391
Investment management costs 14 - 14 21 - 21
1,626 - 1,626 1,412 - 1,412
Charitable activities: 6
Patient's welfare and amenities 968 110 1,077 271 382 653
Staff welfare and amenities 85 - 85 83 58 141
Research 178 178 462 - 462
Purchase of equipment 132 11 143 327 7 334
Staff education & training 213 - 213 235 - 235
Building & associated works 773 55 828 128 151 279
Other charitable activities 214 - 214 182 12 194
2,564 176 2,740 1,688 610 2,298
Total expenditure 4,190 176 4,365 3,100 610 3,710
Net gains / (losses) on investments 474 - 474 567 - 567
Net income / (expenditure) 7 (158) (70) (229) 366 (242) 124
Transfers between funds 21 - - - - - -
Other gains / (losses)
Loss on revaluation of herritage assets 13 (54) - (54) - - -
Net movement in funds (212) (70) (283) 366 (242) 124
Reconciliation of funds
Funds at the beginning of the period 18,518 160 18,678 18,152 402 18,554
Funds at the end of the period 18,306 90 18,396 18,518 160 18,678
----- End of picture text -----

All of the above results are derived from continuing activities. There were no other recognised gains or losses other than those stated above. Movements in restricted funds are disclosed in note 21.1 to the financial statements.

37

University Hospitals Bristol & Weston Charity

Statement of Cash Flows

For the Year Ended 31 March 2025

Cash flows from operating activities:
Net cash used in operating activities (see below)
Cash flows from investing activities:
Dividends, interest and rents from investments
Purchase of fixed assets
Proceeds from sale of investments
Net cash provided by investing activities
Cash flows from financing activities:
Repayments of borrowing
Net cash used in financing activities
Change in cash and cash equivalents in the reporting period
Cash and cash equivalents at the beginning of the reporting period
Cash and cash equivalents at the end of the reporting period
Reconciliation of net income/(expenditure) to net cashflow operating activities
Net income/(expenditure) for the reporting period
Adjustments for:
Depreciation charges
(Gains)/Losses on investments
(Gains)/Losses on heritage assets
Dividends, interest and rents from investments
(Increase)/Decrease in debtors
Decrease in creditors
Net cash used in operating activities
Analysis of cash and cash equivalents
Cash at bank
Total cash and cash equivalents
Year to
31.03.2025
£ '000's
(2,324)
1,052
(4)
411
1,459
(470)
(470)
(1,335)
2,287
952
(283)
31
(474)
54
(1,052)
(136)
(464)
(2,324)
952
952
Year to
31.03.2024
£ '000's
(1,686)
950
-
10
960
(438)
(438)
(1,164)
3,451
2,287
124
.
44
(567)
-
(950)
152
(489)
(1,686)
2,287
2,287

38

University Hospitals Bristol & Weston Charity

Statement of Cash Flows

For the Year Ended 31 March 2025

Analysis of Changes in Net Debt

Cash and cash equivalents
Cash
Borrowings
Loans falling due within one year
Loans falling due after more than one year
Total
At 01.04.2024
Cash-flows
Other non-
cash changes
At 31.03.2025
£'000's
£'000's
£'000's
£'000's
2,287
(1,335)
-
952
2,287
(1,335)
-
952
(470)
470
(504)
(504)
(634)
-
504
(130)
(1,104)
470
-
(634)
1,183
(865)
-
318

39

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

1. Accounting policies

The principal accounting policies adopted in the preparation of the financial statements are set out below. They have been applied consistently during the year and in the preceding year.

1.1 Basis of preparation

These financial statements are prepared on a going concern basis, under the historical cost convention, as modified by the revaluation of investments and fixed asset land & buildings being measured at fair value through income and expenditure within the Statement of Financial Activities.

The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). The Charity is a public benefit entity for the purposes of FRS 102 and therefore the Charity also prepared its financial statements in accordance with the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (The FRS 102 Charities SORP including update Bulletin 2), the Companies Act 2006 and the Charities Act 2011.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the neared one thousand pounds.

The principal accounting policies adopted in the preparation of the financial statements are set out below.

1.2 Going concern

The trustees have assessed whether the use of the going concern basis remains appropriate and have considered possible events or conditions, including the ongoing cost of living crisis, inflationary pressures and wider economic uncertainty, that might cast significant doubt on the charity’s ability to continue as a going concern. The trustees have carried out this assessment for a period of at least twelve months from the date of approval of these financial statements.

In making this assessment, the trustees have reviewed the charity’s forecasts and cash flow projections, taking into account potential pressures on donations, legacies and investment income, alongside rising operational costs, with the situation kept under regular review. After making appropriate enquiries, the trustees are satisfied that the charity has adequate resources to continue in operational existence for the foreseeable future.

Accordingly, the charity continues to adopt the going concern basis in preparing its financial statements.

1.3 Basis of consolidation These consolidated financial statements include the financial statements of University Hospitals Bristol & Weston Charity and Education Centre Management Limited company number 04026846, its wholly owned subsidiary made up to 31 March 2025. These financial statements consolidate the results of the charity and its wholly owned subsidiary on a line by line basis. The results of the subsidiary are disclosed in note 12 to these financial statements.

1.4 Income

All income is included in the Statement of Financial Activities when all of the following criteria are met:

Intangible income

Intangible income is included in the financial statements with an equivalent amount in expenditure. If there is a financial cost borne by another party the value placed on such income is the financial cost of the third party providing the resources.

Legacy income

Legacy gifts are recognised on a case by case basis following the granting of probate when the administrator/executor for the estate has communicated in writing both the amount and settlement date. In the event that the gift is in the form of an asset other than cash or a financial asset traded on a recognised stock exchange, recognition is subject to the value of the gift being reliably measurable with a degree of reasonable accuracy and the title to the asset having been transferred to the Charity.

Lottery income

Lottery income is recorded gross of prize money and other expenditure. Income is typcially recognised at the point of receipt.

40

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

1.4 Income (continued)

Investment income

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the bank. Dividends are recognised once the dividend has been declared and notification has been received of the dividend due. This is normally upon notification by our investment advisor of the dividend yield of the investment portfolio.

1.5 Expenditure

Liabilities and constructive obligations are recognised in the Statement of Financial Activities when approval has been given by the Trustees and this has been confirmed in writing to the applicant. All charitable activities expenditure relates to grants awarded and there are no directly undertaken activities.

Exemptions to this are as follows:

Commitments which are dependent upon explicit conditions being met, and that remain within the control of the charity, are treated as contingent liabilities where those conditions have not yet been met.

Central support costs have been allocated to funds on the basis of the proportion of grant funded activity in the year.

1.6 Tangible fixed assets

Capitalisation

All assets with a cost equal to or greater than £500 are capitalised.

Valuation

Fixed assets are valued as follows:

i Equipment is valued at the lower of estimated net replacement cost or recoverable amount. ii Assets in the course of construction are valued at current cost.

Depreciation

i Depreciation is not charged on each of the following: land and assets in the course of construction. ii Equipment and buildings are depreciated over the estimated life of the asset using the following standard lives:

Buildings 50 years Improvements to property 10 years Computer & associated equipment 5 years Fixtures and fittings 5 years Hot air balloon 5 years

Donated assets

Donated assets are capitalised at their valuation on full replacement cost basis on receipt and are re-valued and depreciated as described above.

1.7[Intangible fixed assets]

Software assets and improvements are capitalised as intangible fixed assets where they are capable of being used for more than one year. The assets are valued at cost less accumulated amortisation.

Software assets are amortised over the estimated life of the asset, which is 5 years.

41

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

1.8 Investment fixed assets a) Investment assets are shown at market value.

1.9 Cash and cash equivalents Cash and cash equivalents include cash at bank and in hand, together with amounts held and cash held within our investment portfolio, by our investment managers Cazenove. These balances are available at short notice and carry minimal risk of changes in value. 1.10 Heritage assets

Heritage assets are included at the Trustees’ best estimate of market value. The Charity has determined this by reference to actual sale proceeds received post year-end and an updated valuation of the remaining assets as at September 2025, which reflects the expected market value for an auction due to be held in December 2025. 1.11 Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership of the leased asset to the Charity. All other leases are classified as operating leases.

Finance leases are shown within debtors, "Finance Lease Receivables", at the amount equivalent to the capital repayment for the remaining life of the lease. The interest element received is credited and the interest element payable is charged, to the Statement of Financial Activities over the period of the mortgage repayment. Operating lease rentals are credited to the Statement of Financial Activities on a straight-line basis over the term of the lease.

1.12 Financial instruments 1.13 Pension costs

The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value, and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

The charity operates two pension provisions. Staff who were formerly employed by the Old Charity, participate in the NHS Pension Scheme. New employees participate in a direct contribution scheme set up by the new entity to which the employer's contribution matches that of the employee up to a maximum of 8%.

1.14[Judgements and key sources of estimation uncertainty]

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and assumptions that affect the amounts reported for income and expenditure during the period. However, the nature of estimation means that actual outcomes could differ from those estimates. The following judgements are considered by the Trustees to have the most significant effect on amounts recognised in the financial statements.

The most significant area of uncertainty that would affect the carrying value of assets held by the Charity is the level of investment return and the performance of investment markets (see investments policy section of the Trustees' Annual Report for more information).

The charity's investment property portfolio is included in the financial statements at a valuation as described in note 12 to the financial statements. This is considered to be a key accounting estimate in view of the amounts involved and the judgements applied in their valuation.

42

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

2.
Other trading activities
Lottery
Community & individual giving
3.
Gross investment income
UK Investments
Investment properties
Listed stock exchange investments
Current asset interest
Year to
31.03.2025
£ '000's
843
88
930
Year to
31.03.2025
£ '000's
563
477
12
1,052
Year to
31.03.2024
£ '000's
551
62
613
Year to
31.03.2024
£ '000's
400
472
78
950

4. Cost of raising funds - fundraising costs

Staff costs
Lottery costs
Office costs
Promotional costs
Events
Other
Unrestricted
Funds
£ '000's
672
708
33
105
31
63
1,612
Restricted
Funds
£ '000's
-
-
-
-
-
-
Year to
31.03.2025
£ '000's
672
708
33
105
31
63
1,612
Year to
31.03.2024
£ '000's
598
561
30
102
17
83
1,391

5. Governance and support costs

The breakdown of support costs and how these were allocated between governance and other support costs is shown in the table below:

Staff costs
Office expenses
Establishment costs
Professional fees
Insurance
Depreciation
Miscellaneous costs
Trustee-related costs
External audit
Interest payable
Other charitable activities
Governance
£ '000's
26
3
7
2
1
1
1
20
62
66
-
129
Support costs
£ '000's
526
56
150
11
28
30
8
-
-
810
-
214
1,024
Year to
31.03.2025
£ '000's
551
59
158
13
29
31
9
1
20
872
66
214
1,153
Year to
31.03.2024
£ '000's
505
Staff time
51
Staff time
174
Staff time
12
Actual
27
Staff time
45
Staff time
2
Staff time
8
Actual
20
Actual
844
98
194
1,136

43

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

5. Governance and support costs (continued)

The total support costs attributable to charitable activities is apportioned based on the proportion of grant funded activity in they year shown in the table below. All governance costs are met by unrestricted funds and no allocation is made to restricted funds for governance related costs.

Patient's welfare and amenities
Staff welfare and amenities
Research
Purchase of equipment
Staff education & training
Building & associated works
Year to
31.03.2025
£ '000's
400
32
66
53
79
308
938
Year to
31.03.2024
£ '000's
292
63
207
150
105
125
942

6. Charitable expenditure

The charity did not undertake any direct charitable activities of its own accord during the period. Grants that were approved in favour of beneficiaries are shown on the face of the Statement of Financial Activities, in line with the approval limits below. The Charity then either reimburses expenditure incurred by beneficiaries or pays third parties directly in respect of goods or services supplied in pursuance of these grants. Central support costs have been allocated against levels of grant funding and so charitable activities shown on the face of the Statement of Financial Activities represents the grants made in the period plus central support costs. A further analysis of the total value of grants made to each hospital and other beneficiaries for whom funds are held is given in note 21.

The approval limits under delgated authority from Trustees which were in operation during the year-ended 31st March 2025 were as follows:

Amount Approver Under £250 Head of Grants / Grants Manager £250 - £1,000 Head of Grants £1,001 - £2,500 Director of Finance £2,501 - £7,500 Two members of the Senior Management Team (SMT) £7,501 - £15,000 Two members of SMT and the Chair of Trustees £15,001 - £50,000 Finance & Grants Committee (F&G) £50,001 & above Full Trustee Board after recommendation by F&G

6.1. Analysis of charitable expenditure

Patient's welfare and amenities
Staff welfare and amenities
Research
Purchase of equipment
Staff education & training
Building & associated works
Other charitable activities
Grant
funded
activity
£ '000's
677
54
112
90
134
520
-
1,587
Support and
governance
costs
£ '000's
400
32
66
53
79
308
214
1,153
Year to
31.03.2025
£ '000's
1,077
85
178
143
213
828
214
2,740
Year to
31.03.2024
£ '000's
653
141
462
334
235
279
194
2,298

44

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

6.2. Analysis of grants expenditure in year

Patients' welfare and amenities
Staff welfare and amenities
Research
Purchase of equipment
Staff education & training
Building & associated works
Grants to
Institutions
£ '000's
-
-
112
90
-
520
Grants to
Individuals
£ '000's
677
54
-
-
134
-
Year to
31.03.2025
£ '000's
677
54
112
90
134
520
722 865 1,587
Recipients of material institutional grants approved in year
University Hospitals Bristol & Weston NHS Foundation Trust
Year to
31.03.2025
£ '000's
1,865
Year to
31.03.2024
£ '000's
1,451
1,865 1,451
7.
Net income/(expenditure)
This is stated after charging the following:
Year to
Year to
31.03.2025
31.03.2024
£ '000's
£ '000's
19
19
1
2
Auditor's remuneration- audit fee
Grants approved to institutions during the year totalled £1,865k (prior year £1,451k). This may differ to the
analysis of grants expediture shown above due to the impact of any changes to commitment values and write-
offs of any remaining balances at the end of a completed project.
Auditor's remuneration- tax advice
8.
Salaries and wages
Social security costs
Pension costs
Staff costs and numbers
Staff costs were as follows:
Year to
31.03.2025
£ '000's
1,001
98
88
Year to
31.03.2024
£ '000's
902
86
79
1,187 1,067

The number of employees who earned more than £60,000, during the period was as follows:

Fundraising
Grants
Other Charity Staff
Total
£60,000 - £69,999
The average number of employees in the period was as follows:
£70,000 - £79,999
£80,000 - £89,999
Year to
31.03.2025
No.
-
2
1
Year to
31.03.2025
No.
18
4
7
29
Year to
31.03.2024
No.
2
-
1
Year to
31.03.2024
No.
17
4
7
28

45

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

8. Staff costs and numbers (continued)

The Charity considers its key management personnel comprises the Trustees, the Chief Executive, the Director of Finance and Operations and the Director of Fundraising & Marketing. The total employment benefits including pension contributions of the key management personnel were £276,316 for the year (2024: £263,511). The increase in salary reflects an annual inflationary pay award.

9. Trustee and connected persons transactions

No remuneration has been paid to the Trustees during the period (2024: Nil)

No expenses were claimed by or reimbursed to Trustees during the period (2024: Nil).

During the year Trustees donated £1,679 to the Charity (2024: £65)

An indemnity provision of £3,000,000 has been taken out by the Charity at a cost of £2,922 (2024: £2,922).

10. Tangible fixed assets- group and charity

Cost or valuation:
Balance at beginning of period
Additions
Disposals
Balance at end of period
Accumulated depreciation
Balance at beginning of period
Charge for period
Eliminated on disposal
Balance at end of period
Net book value at 31 March 2025
Net book value at 31 March 2024
Improvements
to property
£ '000's
147
-
-
147
69
15
-
83
64
78
Hot air
balloon
£ '000's
18
-
(18)
-
18
-
(18)
-
-
-
Fixtures and
fittings
£ '000's
130
-
-
130
117
13
-
130
-
13
Office
equipment
£ '000's
57
4
-
61
51
3
-
54
6
5
31.03.2025
Total
£ '000's
352
4
(18)
338
256
31
(18)
268
70
97

11. Intangible fixed assets - group and charity

Cost or valuation:
Balance at beginning of period
Additions
Balance at end of period
Accumulated depreciation
Balance at beginning of period
Charge for period
Balance at end of period
Net book value at 31 March 2025
Net book value at 31 March 2024
Historic cost at 31 March 2025
Historic cost at 31 March 2024
Software
£ '000's
4
-
4
4
1
4
-
1
4
4
31.03.2025
Total
£ '000's
4
-
4
4
1
4
-
1
4
4

46

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

12. Fixed asset investments

Market value at beginning of period
Less: Disposals at opening market value
Net gains/ (losses) on revaluation
Investment in a
Common Deposit/
Investment
Investment
Total
properties
Fund
31.03.2025
£ '000's
£ '000's
£ '000's
6,340
10,941
17,281
-
(411)
(411)
780
(309)
471
7,120
10,221
17,341
Total
31.03.2024
£ '000's
16,724
(10)
567
17,281

The properties held as fixed asset investments are shown at market valuation. Valuations are carried out professionally and reviewed at each reporting period with a full valuation undertaken when the trustees deem necessary. A full valuation in accordance with the RICS Valuation – Global Standards 2025 and the UK National Supplement effective from 1 May 2024 and reissued in January 2025 (Red Book), FRS102 and the SORP for Charities, was undertaken by a third party, Alder King, in September 2025. The Trustees are satisfied that the valuations remain appropriate and represents the best estimate of fair value as at the balance sheet date.

Market values

Investment properties
Common Deposit Fund/Common Investment Fund
Investment in subsidiary undertakings
Portfolio content
Multi-Asset fund
Group
31.03.2025
£ '000's
7,120
10,221
-
17,341
Group
31.03.2024
£ '000's
6,340
10,941
-
17,281
Charity
31.03.2025
£ '000's
7,120
10,221
-
17,341
31.03.2025
£ '000's
10,221
10,221
Charity
31.03.2024
£ '000's
6,340
10,941
-
17,281
31.03.2024
£ '000's
10,941
10,941

Charity investment in subsidiary undertaking

The charity has a wholly owned trading subsidiary, which is incorporated in the UK. Education Centre Management Limited (company no: 04026846) facilitates management services to the University Hospitals Bristol & Weston NHS Foundation Trust's Education Centre. The following is an extract of the company's financial statements for the period to 31 March 2025:

Income
Expenditure
Net income/(loss)
Gift aid payable to parent charity
Net movement in funds
Year to
31.03.2025
£ '000's
320
(320)
-
-
-
Year to
31.03.2024
£ '000's
321
(321)
-
-
-

47

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

13. Heritage assets

Carrying amount at beginning period
Net gains/ (losses) on revaluation
14.
Debtors
Amounts falling due within one year
Trade debtors
Intercompany debtors
Finance lease receivables
Prepayments and accrued income
Other debtors
Total due within one year
Amounts falling due after more than one year
Finance lease receivables
Total debtors
Group
31.03.2025
£ '000's
29
-
504
1,208
2
1,743
1,222
2,965
Group
31.03.2024
£ '000's
37
-
482
581
2
1,102
1,727
2,829
Total
Total
31.03.2025
31.03.2024
£ '000's
£ '000's
92
92
(54)
-
38
92
Charity
Charity
31.03.2025
31.03.2024
£ '000's
£ '000's
29
37
14
15
504
482
1,208
581
-
-
1,756
1,115
1,222
1,727
2,978
2,842

The Charity received £608,500 (2024: £608,500) for the use of the Education Centre. In the period to 31 March 2025 £481,717 (2024: £460,197) relates to the repayment of capital. The finance lease expires in 2028.

15. Creditors: amounts falling due within one year

Loans and overdrafts
Trade creditors
Accruals and deferred income
Other creditors
Commitments
Group
31.03.2025
£ '000's
504
338
238
67
1,693
2,841
Group
31.03.2024
£ '000's
470
1,034
244
63
1,464
3,275
Charity
Charity
31.03.2025
31.03.2024
£ '000's
£ '000's
504
470
319
1,017
235
240
67
63
1,693
1,464
2,818
3,254

Trade creditors includes £234k (2024: £914k) owed to University Hospitals Bristol & Weston NHS Foundation Trust in respect of various grants awarded to them. These have all been paid after the year-end.

48

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

16. Creditors: amounts falling due after more than one year

Loans and overdrafts Group
31.03.2025
£ '000's
130
130
Group
31.03.2024
£ '000's
634
634
Charity
Charity
31.03.2025
31.03.2024
£ '000's
£ '000's
130
634
130
634

An original loan of £3,169,265 was provided by the Bank of Ireland to refinance previous borrowings provided by the Bank of the Old Charity, which had been borrowed to fund the construction of the Education Centre, Upper Maudlin Street, Bristol. The loan is secured on the site and repayable, at 7.14% interest, in equal instalments over 93 months (7.75 years) from October 2018. The balance remaining at 31 March 2025 was £634k (2024: £1,104k).

The loans and overdrafts balance falls due as follows:

Not later than one year (see note 15)
Later than one year and not later than five years
Group
31.03.2025
£ '000's
504
130
634
Group
31.03.2024
£ '000's
470
634
1,104
Charity
Charity
31.03.2025
31.03.2024
£ '000's
£ '000's
504
470
130
634
634
1,104

17. Related parties

The Charity Trustees receive and administer the charitable funds for the Hospitals, Wards and Departments of University Hospitals Bristol & Weston NHS Foundation Trust and its associated bodies formerly known as Bristol Clinical Commissioning Group, Bristol Community Health, North Somerset Clinical Commissioning Group, North Somerset Community Partnership and South Bristol Community Hospital. The objectives of University Hospitals Bristol & Weston Charity are to provide grants that will be for the ultimate benefit to patients using the hospitals within University Hospitals Bristol & Weston NHS Foundation Trust and healthcare facilities within the relevant community partnerships. These grants may be for medical equipment, patient and staff facilities, staff training and medical research.

In addition, University Hospitals Bristol & Weston NHS Foundation Trust also incur the costs of equipment, salaries and other grant related expenditure on behalf of the Charity for which they are fully reimbursed.

The Charity leases property to its subsidiary Education Centre Management Limited who in turn leases the property to University Hospitals Bristol & Weston NHS Foundation Trust. The value of invoices raised by both organisations was £608,500 (2024: £608,500). The amount owed to the Charity and Education Centre Management Limited in respect of these invoices at 31 March 2025 was £nil (2024: £nil).

The Charity leases other properties and land to University Hospitals Bristol & Weston NHS Foundation Trust. During the year, the Charity issued rental invoices to University Hospitals Bristol & Weston NHS Foundation Trust totalling £297,011 (2024: £285,250). The amount owed to the Charity in respect of these invoices at 31 March 2025 was £nil (2024: £nil). In addition, at 31 March 2025 the Charity has recognised an accrual totalling £184,520 in relation to back rent due from the Trust, which was not invoiced as the rent review took place after the year-end.

The Charity charges its subsidiary, Education Centre Management Limited management and service charges. During the year, the Charity charged Education Management Limited £34,984 (2024: £32,283). The amount owed to the Charity in respect of these invoices at 31 March 2025 was £12,000 (2024: £12,000).

49

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

18. Operating leases income

At the reporting date the charity had outstanding minimum future receipts from non-cancellable operating leases, which fall due as follows:

Not later than one year
Later than one year and not later than five years
Later than five years
31.03.2025
£ '000's
415
1,583
748
2,746
31.03.2024
£ '000's
292
1,285
997
2,574

Operating leases expenditure

At the reporting date the charity had outstanding minimum future payments under non-cancellable operating leases, which fall due as follows:

Not later than one year
Later than one year and not later than five years
Later than five years
31.03.2025
£ '000's
150
497
-
647
31.03.2024
£ '000's
93
570
50
713

19. Members' Liability

The charitable company is limited by guarantee, not having a share capital, and consequently the liability of members is limited, subject to an undertaking by each member to contribute to the net assets or liabilities of the charitable company on winding up such amounts as might be required not exceeding £1.

50

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

20. Analysis of net assets by fund

Tangible fixed assets
Intangible fixed assets
Investments
Heritage assets
Long term debtors
Current assets
Current liabilities
Creditors due after more than one year
Tangible fixed assets
Intangible fixed assets
Investments
Heritage assets
Long term debtors
Current assets
Current liabilities
Creditors due after more than one year
Unrestricted
Funds
£ '000's
70
-
17,341
38
1,222
2,605
(2,841)
(130)
18,306
Unrestricted
Funds
£ '000's
97
1
17,281
92
1,727
3,229
(3,275)
(634)
18,518
Restricted
Funds
£ '000's
-
-
-
-
-
90
-
-
90
Restricted
Funds
£ '000's
-
-
-
-
-
160
-
-
160
Total
31.03.2025
£ '000's
70
-
17,341
38
1,222
2,695
(2,841)
(130)
18,396
Total
31.03.2024
£ '000's
97
1
17,281
92
1,727
3,389
(3,275)
(634)
18,678

21. Analysis of funds

The Charity holds restricted, unrestricted and endowment funds for the University Hospitals Bristol & Weston NHS Foundation Trust and former Community Partnerships and local Clinical Commissioning Groups (CCGs). The restricted funds arise where money is held which can only be used for a specific purpose. Within the unrestricted funds there is one undesignated fund, the rest being designated funds. Of the designated funds there is one general purpose fund for each of the hospitals, former CCGs and community services, the rest being held for the benefit of patients, staff, research, training and education, equipment and specific projects.

Transfers arise where a contribution is made by one fund towards the income or expenditure of another or where there is the transfer of a balance to another NHS charity so that it follows the service or department to which it relates.

51

University Hospitals Bristol & Weston Charity

Notes to the Financial Statements

For the Year Ended 31 March 2025

21.1. Analysis of funds (continued)

Restricted funds:
Bristol Dental Hospital
Bristol Eye Hospital
Bristol Haematology & Oncology Centre
Bristol Heart Institute
Bristol Royal Hospital for Children
Bristol Royal Infirmary
St. Michael's Hopsital
Weston General Hospital
University Hospitals Bristol & Weston Charity
University Hospitals Bristol & Weston NHS Foundation Trust
Unrestricted funds:
Designated
Bristol Clinical Commissioning Group & Bristol Community Health
Bristol Dental Hospital
Bristol Eye Hospital
Bristol Haematology & Oncology Centre
Bristol Heart Institute
Bristol, North Somerset, South Glos Clinical Commissioning Group
Bristol Royal Infirmary
Research Committee
South Bristol Community Hospital
St Michael's Hospital
Weston General Hospital
University Hospitals Bristol & Weston Charity
University Hospitals Bristol & Weston NHS Foundation Trust
Undesignated
University Hospitals Bristol & Weston Charity Undesignated Reserves
Unrestricted Trading Subsidiary
Total All Funds
Restricted funds:
Bristol Dental Hospital
Bristol Eye Hospital
Bristol Haematology & Oncology Centre
Bristol Heart Institute
Bristol Royal Hospital for Children
St. Michael's Hopsital
Weston General Hospital
University Hospitals Bristol & Weston Charity
University Hospitals Bristol & Weston NHS Foundation Trust
Unrestricted funds:
Designated
Bristol Clinical Commissioning Group & Bristol Community Health
Bristol Dental Hospital
Bristol Eye Hospital
Bristol Haematology & Oncology Centre
Bristol Heart Institute
Bristol, North Somerset, South Glos Clinical Commissioning Group
Bristol Royal Infirmary
Research Committee
South Bristol Community Hospital
St Michael's Hospital
Weston General Hospital
University Hospitals Bristol & Weston Charity
University Hospitals Bristol & Weston NHS Foundation Trust
Undesignated
University Hospitals Bristol & Weston Charity Undesignated Reserves
Unrestricted Trading Subsidiary
Total All Funds
Bristol Royal Hospital for Children
Bristol Royal Hospital for Children
Balance
31 March
2024
£ '000's
38
13
-
8
4
7
-
74
10
6
160
-
221
1,856
2,863
1,077
150
2,161
2,186
1,895
369
268
519
1,976
1,683
17,224
1,293
1
1,294
18,678
Balance
31 March
2023
£ '000's
-
-
31
8
248
-
84
22
2
402
74
235
1,871
2,672
1,087
76
1,503
2,376
2,140
262
387
519
2,347
1,351
16,900
1,251
1
1,252
18,554
Income
£ '000's
5
-
6
39
10
40
4
-
106
-
1
77
23
30
-
383
48
(2)
(33)
14
28
6
536
1,110
2,128
320
2,447
3,662
Income
£ '000's
38
13
2
74
229
2
-
-
5
368
-
-
(1)
234
124
-
71
49
(35)
110
12
59
-
253
876
1,702
321
2,023
3,267
Expenditure
£ '000's
(44)
(13)
(6)
(9)
(39)
(9)
(40)
(17)
-
-
(176)
-
(44)
35
(93)
(109)
-
(71)
(330)
24
(6)
(75)
(266)
(79)
(397)
(1,411)
(2,564)
(214)
(2,778)
(4,365)
Expenditure
£ '000's
-
-
(33)
(74)
(473)
(2)
(10)
(12)
(1)
(610)
-
(14)
(14)
(62)
(134)
-
600
(143)
(220)
(3)
(212)
(52)
(66)
(232)
(552)
(2,354)
(194)
(2,548)
(3,710)
Gain/(loss) on
investments
£ '000's
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
420
-
420
420
Gain/(loss) on
investments
£ '000's
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
567
-
567
567
Net transfers
£ '000's
-
-
-
-
-
-
-
-
-
-
-
-
5
-
9
-
-
(31)
5
(12)
-
59
25
(46)
(13)
-
105
(105)
()
()
Net transfers
£ '000's
-
-
-
-
-
-
-
-
-
-
(74)
-
-
19
-
74
(13)
(96)
10
-
81
(7)
(305)
311
-
127
(127)
-
-
Balance
31 March
2025
£ '000's
-
-
-
(1)
4
8
-
62
10
6
90
-
182
1,968
2,802
997
150
2,442
1,909
1,905
330
266
305
1,857
1,809
16,923
1,382
1
1,383
18,396
Balance
31 March
2024
£ '000's
38
13
-
8
4
-
74
10
6
160
-
221
1,856
2,863
1,077
150
2,161
2,186
1,895
369
268
519
1,976
1,683
17,224
1,293
1
1,294
18,678

52